Business Wire

Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments

Share

PaaS leader ensures seamless migrations and uninterrupted payment operations

Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format.

SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of annual net turnover.

SWIFT SRG 2025 is another seismic update, representing the biggest global mandate for the payments industry in more than half a century. SWIFT payments have historically been processed via the legacy MT messaging format, but this year XML-based ISO 20022 MX messaging became the new global standard for the highest volume SWIFT cross-border payment messages. The new format offers increased global interoperability, richer data, improved fraud detection, and operational efficiency. Failing to adapt is not an option: the network no longer supports MT messages after the November 22nd deadline.

Meeting these regulations proved a distinct challenge for banks, due to the tight timelines involved, operational complexity, and the constraints of legacy infrastructure. As such, many were unprepared or left making changes until the last minute: Volante’s Big Survey 2025 found that, as of May 2025, only 36% of Dutch banks and 39% of Belgian banks were offering SEPA Instant Payments. Additionally, one in seven (14%) EMEA banks were still exploring options for SWIFT ISO 20022 compliance, only a few months before the deadline.

As a trusted modernization partner, Volante guided European and global customers as they prepared to meet the SEPA IPR 2025 and SWIFT SRG 2025 mandate deadlines. Supporting clients across multiple geographies, using both PaaS and on-premise infrastructure, Volante leveraged its ISO-native payments platform to deliver a seamless, disruption-free migration. Over a 48-hour ‘go-live’ weekend, all customers were successfully upgraded to the ISO 20022 MX format, ensuring full compliance across both mandates.

“Volante’s support and solutions were integral to our successful migration,” said Philip Benson, Senior Operations Manager at QIB (UK) plc. “Transition periods are normally a source of stress for businesses, as any disruption can wreak havoc on services, customers, and their users. But this wasn’t the case here. Partnering with Volante meant migration occurred instantly and operations continued optimally. These upgrades, powered by Volante’s advanced technology, allow us to fully embrace the future of payments and drive even more value for our customers.”

“For more than two decades, our customers have relied on us as true partners in their modernization journey,” said Vijay Oddiraju, CEO at Volante Technologies. “Their continued trust — reflected in these two successful regulatory upgrades — is something we are deeply proud of. Both migrations had complicated elements but SRG 2025 was particularly complex, as it involved both technology and operational changes. However, regardless of the deployment model, we were able to help all our customers achieve compliance without disruption, delivering the level of service Volante customers have come to expect — and rightfully so. Our solutions and support enable banks to comply today and innovate tomorrow.”

“Volante’s platform was built to be ISO-native and real-time ready, enabling seamless compliance and unlocking new opportunities for innovation," said Deepak Gupta, Chief Product, Engineering, and Delivery Officer at Volante. “With this migration, banks have gained the ability to offer instant payments and ISO 20022-based services, to not only maintain compliance but future-proof their infrastructure.”

Many banks met the SRG 2025 deadline by layering tactical fixes, such as message translation or transformation tools, on top of legacy payment systems. With compliance now achieved, this is the ideal moment to move toward ISO-native platforms to unlock the full value of ISO 20022 data.

The wave of compliance deadlines has yet to crest. In 2027, SEPA Instant Payment rules will apply to non-Euro area member states, meaning banks in countries such as Poland and Sweden should begin preparing for instant payments now. Volante will continue partnering with customers to help them adopt ISO-native, real-time capabilities and use these foundations to deliver value-added services into 2026 and beyond.

To learn more about Volante Technologies SEPA Instant Payments, please visit https://www.volantetech.com/sepa-instant-payments/. To learn more about Volante SWIFT cross-border payments, please visit https://www.volantetech.com/cross-border-payments/.

Notes to editors

About Volante Technologies

Volante Technologies is the trusted cloud payments modernization partner to financial businesses worldwide, giving them the freedom to evolve and innovate at record speed. Real-time native, API-enabled, and ISO 20022 fluent, Volante's Payments as a Service and underlying low-code platform process millions of mission-critical transactions and trillions in value daily. Volante’s customers include four of the top five global corporate banks, seven of the top ten U.S. banks, and two of the world’s largest card networks. Learn more at www.volantetech.com andlinkedin.com/company/volante-technologies.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251216219100/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

1GLOBAL Empowers Revolut to Offer Mobile Plans in Poland16.12.2025 13:04:00 CET | Press release

1GLOBAL, a technology-driven global mobile communications provider, strengthens its partnership with Revolut, expanding the leading neobank’s mobile data plan offering to the Polish market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216769985/en/ 1GLOBAL strengthens its partnership with Revolut, expanding the leading neobank’s mobile data plan offering to the Polish market. By integrating 1GLOBAL’s eSIM capability into its multi-service app, Revolut’s customers in Poland who signed up to the waitlist can now enjoy bundled mobile plans that include competitively priced domestic data plans starting at zł 25 per month (approx. €6.00 per month) with unlimited calls and texts in Poland and the EU, in just a few taps. For 1GLOBAL, this expansion marks another milestone in the company’s embedded telco services strategy. The services are trusted by more than 4,000 corporate partners across a variety of industries including fi

Dompé Doses First Patients in Europe and US in Phase 3 Studyof Isocyclosporin for Atopic Keratoconjunctivitis16.12.2025 13:00:00 CET | Press release

Atopic keratoconjunctivitis(AKC) is a chronic inflammatory disease of the eye that is frequently associated with atopic conditions, and limited disease awareness often leads to delayed or missed diagnosis. Isocyclosporin is a novel, dual inhibitor oftwo critical immunepathways in ocular inflammation like AKC. Dompé, a leading biopharmaceutical company with operations in Italy and the U.S., announced the first patients have been enrolled in a Phase 3 study of Isocyclosporin for the treatment of atopic keratoconjunctivitis (AKC). Isocyclosporin is a dual inhibitor of transient receptor potential (TRP) cation channel, mucolipin subfamily, member 2 (TRPML2) and calcineurin, key regulators of immune and inflammatory response in chronic inflammatory eye diseases. The Phase 3 trial is a multicenter, randomized, double-masked study comparing isocyclosporin against vehicle control in improving ocular signs and symptoms after six weeks of treatment. “This milestone underscores Dompé’s commitment

Visa Launches Stablecoin Settlement in the United States, Marking a Breakthrough for Stablecoin Integration16.12.2025 13:00:00 CET | Press release

With more than $3.5B in annualized stablecoin settlement volume1, Visa brings USDC settlement to U.S. institutions. Visa Inc. (V) today announced the launch of USDC settlement in the United States, marking a major milestone in the company’s stablecoin settlement pilot program and strategy to modernize its settlement layer underpinning global commerce. For the first time, U.S. issuer and acquirer partners can settle with Visa in Circle’s USDC, a fully reserved, dollar-denominated stablecoin. With USDC settlement, issuers can benefit from faster funds movement over blockchains, seven‑day availability and enhanced operational resilience across weekends and holidays - without any change to the consumer card experience. Initial banking participants include Cross River Bank and Lead Bank, which have started settling with Visa in USDC over the Solana blockchain. Broader availability in the U.S. is planned through 2026. Additionally, Visa is a design partner for Arc, a new Layer 1 blockchain d

TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release

TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver

RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release

RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye